Tehran University of Medical Sciences

Science Communicator Platform

Share By
Global Interest in Vaccines During the Covid‐19 Pandemic: Evidence From Google Trends Publisher



Khakimova A1 ; Abdollahi L2 ; Zolotarev O3 ; Rahim F4, 5
Authors

Source: Vaccine: X Published:2022


Abstract

COVID-19 (coronavirus disease 2019) vaccines have become available; now, everyone has the opportunity to get vaccinated. We used Google Trends (GT) data to assess the global public interest in COVID-19 vaccines during the pandemic. For the analysis, a period of 17 months was chosen (from Jan 19, 2020, to Jul 04, 2021). Interest in user queries was tracked by keywords (corona vaccine, COVID-19 vaccine development, Sputnik v, Pfizer vaccine, AstraZeneca vaccine, etc.). The geographic analysis of queries was also carried out. The interest of users in the vaccine is significantly increasing. It is focused on the side effects of vaccines, and users pay attention to vaccines’ developers from different countries. The correlation between the scientific publications devoted to vaccine development and such requests of users on the internet is absent. This study shows that internet search patterns can be used to gauge public attitudes towards coronavirus vaccination. Safety concerns consistently high follow an interest in vaccine side effects. This data can be used to track and predict attitudes towards vaccination of populations from COVID-19 in different countries before global vaccination becomes available to help mitigate the adverse effects of the pandemic. © 2022 The Author(s)
Other Related Docs
4. Pediatric Asthma and Covid-19 Vaccination: Unveiling Patterns of Hesitancy and Acceptance, Therapeutic Advances in Vaccines and Immunotherapy (2024)
6. Feasibility and Effectiveness of Vaccines for Covid-19: An Umbrella Review, Archives of Academic Emergency Medicine (2025)
10. Covid-19 Vaccine Hesitancy in Iranian Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
19. Covid-19 Vaccination Challenges: A Mini-Review, Human Vaccines and Immunotherapeutics (2022)